Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: What some don't understand.

I agree and the present court case is an example of what the costs will be for infringers. Our goal is to make our nuisance value as high as can be and still be a very prudent choice for the infringer. I am hoping the extra money we put in for the licensing effort is paying off.

Feb 2011

Earlier this month Patriot and TPL resolved a number of issues that arose over the past year related to the licensing and litigation activities of the MMP Patent Portfolio. The resolution included an agreement to provide a substantial increase in working capital for the MMP licensing program and patent infringement litigation from MMP licensing proceeds. The increased commitment reflects the companies' recognition of the strength and growing confidence in the MMP Portfolio based on the long string of successes in defeating multiple re-examination attacks in both the USPTO and Europe, as well as the continued pace of the MMP Licensing Program which totals over 80 world-class Licensees to date.

Share
New Message
Please login to post a reply